Matches in SemOpenAlex for { <https://semopenalex.org/work/W2127608961> ?p ?o ?g. }
- W2127608961 endingPage "2033" @default.
- W2127608961 startingPage "2033" @default.
- W2127608961 abstract "There are several nicotine replacement products on the market, and physicians are likely to be asked with increasing frequency about which of these products their patients should use.To provide a basis for rational advice by comparing nicotine polacrilex (gum), a transdermal patch, nasal spray, and an inhaler.Randomized trial with assessments at the quit date and 1, 4, and 12 weeks later.Hospital smokers' clinic.Male and female community volunteers (N = 504) smoking 10 or more cigarettes per day and seeking help to stop smoking.Patients were given brief advice, and purchased their nicotine replacement treatment at approximately half the regular retail price.Nicotine replacement treatment use, ratings of withdrawal symptoms, ratings of product characteristics and helpfulness, and biochemically validated continuous lapse-free abstinence.The products did not differ in their effects on withdrawal discomfort, urges to smoke, or rates of abstinence. The continuous validated 12-week abstinence rates were 20%, 21%, 24%, and 24% in the gum, patch, spray, and inhaler groups, respectively. Compliance with recommended nicotine replacement treatment use was high for the patch, low for gum, and very low for the spray and the inhaler. The spray was underused because of adverse effects more often than the other products. In the subjects using the spray, the level of use among abstainers at week 1 predicted outcome at week 12. The inhaler was rated as more embarrassing to use than the other products, but provided at least as much nicotine as the gum.When asked about nicotine replacement treatment products available, physicians should note that, despite low compliance with the recommended dose of the spray and inhaler and differences in product ratings, overall, there are no notable differences between the products in their effects on withdrawal discomfort, perceived helpfulness, or general efficacy." @default.
- W2127608961 created "2016-06-24" @default.
- W2127608961 creator A5005013018 @default.
- W2127608961 creator A5026551302 @default.
- W2127608961 creator A5027799247 @default.
- W2127608961 creator A5052035076 @default.
- W2127608961 creator A5064290037 @default.
- W2127608961 creator A5069784035 @default.
- W2127608961 date "1999-09-27" @default.
- W2127608961 modified "2023-10-11" @default.
- W2127608961 title "Randomized Comparative Trial of Nicotine Polacrilex, a Transdermal Patch, Nasal Spray, and an Inhaler" @default.
- W2127608961 cites W1974809472 @default.
- W2127608961 cites W1999323355 @default.
- W2127608961 cites W2018354187 @default.
- W2127608961 cites W2023099619 @default.
- W2127608961 cites W2044847088 @default.
- W2127608961 cites W2044906090 @default.
- W2127608961 cites W2050441476 @default.
- W2127608961 cites W2073648650 @default.
- W2127608961 cites W2082992993 @default.
- W2127608961 cites W2157800353 @default.
- W2127608961 doi "https://doi.org/10.1001/archinte.159.17.2033" @default.
- W2127608961 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10510989" @default.
- W2127608961 hasPublicationYear "1999" @default.
- W2127608961 type Work @default.
- W2127608961 sameAs 2127608961 @default.
- W2127608961 citedByCount "230" @default.
- W2127608961 countsByYear W21276089612012 @default.
- W2127608961 countsByYear W21276089612013 @default.
- W2127608961 countsByYear W21276089612014 @default.
- W2127608961 countsByYear W21276089612015 @default.
- W2127608961 countsByYear W21276089612016 @default.
- W2127608961 countsByYear W21276089612017 @default.
- W2127608961 countsByYear W21276089612018 @default.
- W2127608961 countsByYear W21276089612019 @default.
- W2127608961 countsByYear W21276089612020 @default.
- W2127608961 countsByYear W21276089612021 @default.
- W2127608961 countsByYear W21276089612022 @default.
- W2127608961 countsByYear W21276089612023 @default.
- W2127608961 crossrefType "journal-article" @default.
- W2127608961 hasAuthorship W2127608961A5005013018 @default.
- W2127608961 hasAuthorship W2127608961A5026551302 @default.
- W2127608961 hasAuthorship W2127608961A5027799247 @default.
- W2127608961 hasAuthorship W2127608961A5052035076 @default.
- W2127608961 hasAuthorship W2127608961A5064290037 @default.
- W2127608961 hasAuthorship W2127608961A5069784035 @default.
- W2127608961 hasConcept C118552586 @default.
- W2127608961 hasConcept C126322002 @default.
- W2127608961 hasConcept C142724271 @default.
- W2127608961 hasConcept C168563851 @default.
- W2127608961 hasConcept C204787440 @default.
- W2127608961 hasConcept C205679159 @default.
- W2127608961 hasConcept C27081682 @default.
- W2127608961 hasConcept C2775842315 @default.
- W2127608961 hasConcept C2776042228 @default.
- W2127608961 hasConcept C2776087441 @default.
- W2127608961 hasConcept C2777843972 @default.
- W2127608961 hasConcept C2778887763 @default.
- W2127608961 hasConcept C2779547902 @default.
- W2127608961 hasConcept C2780261241 @default.
- W2127608961 hasConcept C2780478649 @default.
- W2127608961 hasConcept C2780687700 @default.
- W2127608961 hasConcept C2780973058 @default.
- W2127608961 hasConcept C42219234 @default.
- W2127608961 hasConcept C71924100 @default.
- W2127608961 hasConcept C85663871 @default.
- W2127608961 hasConcept C98274493 @default.
- W2127608961 hasConceptScore W2127608961C118552586 @default.
- W2127608961 hasConceptScore W2127608961C126322002 @default.
- W2127608961 hasConceptScore W2127608961C142724271 @default.
- W2127608961 hasConceptScore W2127608961C168563851 @default.
- W2127608961 hasConceptScore W2127608961C204787440 @default.
- W2127608961 hasConceptScore W2127608961C205679159 @default.
- W2127608961 hasConceptScore W2127608961C27081682 @default.
- W2127608961 hasConceptScore W2127608961C2775842315 @default.
- W2127608961 hasConceptScore W2127608961C2776042228 @default.
- W2127608961 hasConceptScore W2127608961C2776087441 @default.
- W2127608961 hasConceptScore W2127608961C2777843972 @default.
- W2127608961 hasConceptScore W2127608961C2778887763 @default.
- W2127608961 hasConceptScore W2127608961C2779547902 @default.
- W2127608961 hasConceptScore W2127608961C2780261241 @default.
- W2127608961 hasConceptScore W2127608961C2780478649 @default.
- W2127608961 hasConceptScore W2127608961C2780687700 @default.
- W2127608961 hasConceptScore W2127608961C2780973058 @default.
- W2127608961 hasConceptScore W2127608961C42219234 @default.
- W2127608961 hasConceptScore W2127608961C71924100 @default.
- W2127608961 hasConceptScore W2127608961C85663871 @default.
- W2127608961 hasConceptScore W2127608961C98274493 @default.
- W2127608961 hasIssue "17" @default.
- W2127608961 hasLocation W21276089611 @default.
- W2127608961 hasLocation W21276089612 @default.
- W2127608961 hasOpenAccess W2127608961 @default.
- W2127608961 hasPrimaryLocation W21276089611 @default.
- W2127608961 hasRelatedWork W1533850090 @default.
- W2127608961 hasRelatedWork W1981406038 @default.
- W2127608961 hasRelatedWork W2033936159 @default.
- W2127608961 hasRelatedWork W2057137365 @default.
- W2127608961 hasRelatedWork W2073815162 @default.